Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Assessor-Blinded, Randomised Controlled Trial of Acupuncture to Prevent Chemobrain in Breast Cancer Patients

NCT02457039 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT02457039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02457039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Assessor-Blinded, Randomised Controlled Trial of Acupuncture to Prevent Chemobrain in Breast Cancer Patients
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
March 31, 2019
Enrollment
93 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemo-brain, drug-related side effects and adverse reactions, mild cognitive impairment